This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $5,049.84, is for the delivery of 4,568,183,189 units of the pharmaceutical product Stelara 130 mg/26 ml vial. The contract has a firm fixed price and an ultimate completion date of May 27, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a range of pharmaceutical products to federal agencies, including military and government healthcare facilities. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive portfolio of pharmaceutical items.
Generated 8/4/25, 9:45 AM